In this issue:
Pembrolizumab or placebo with chemotherapy for cervical cancer
Atezolizumab plus bevacizumab and chemotherapy for cervical cancer
Lymph node isolated tumour cells in patients with endometrial cancer
Clinical validation of HPV circulating tumour DNA for cervical cancer
Immunotherapy and chemotherapy combinations for advanced endometrial cancer
Differentiation of survival outcomes by anatomic involvement for endometrial cancer
Pattern of recurrence in endometrial cancer
Trends in gynaecological cancer in Japan
Lenvatinib plus pembrolizumab for endometrial cancer
Recurrence rates and patterns of recurrence in stage IA p53abn endometrial cancer
Please login below to download this issue (PDF)